Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Integral Molecular Inc.

www.integralmolecular.com

Latest From Integral Molecular Inc.

Asia Deal Watch: Boost For Esperion's Cholesterol Candidate As Daiichi Brought On Board

Daiichi Sankyo pays $150m upfront to commercialize Esperion's cholesterol drug and combination in Europe, while Gilead enters major deal worth up to $785m with Korea's Yuhan to bolster its NASH portfolio. Samsung taps 3SBio to build its biosimilars business in China. 
Deals Asia Pacific

Selected Start-Ups (10/02)

In Vivo briefly summarizes the technologies of these recently founded companies: BaroSense Inc., BioMarck Pharmaceuticals Ltd., Integral Molecular Inc., MerLion Pharmaceuticals Pte. Ltd., Nanopoint Inc. and Znomics Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Integral Molecular Inc.
  • Senior Management
  • Ben Doranz, PhD, Pres. & CSO
  • Contact Info
  • Integral Molecular Inc.
    Phone: (215) 966-6018
    3701 market St.
    Ste. 340
    Philadelphia, PA 19104
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register